BLUETTI Launches New AC200L Portable Power Station in Europe on March 13
BERLIN–(BUSINESS WIRE)–BLUETTI, the leading innovator in sustainable energy solutions, is thrilled to announce the upcoming launch of its latest product,... Read more.
SmartStream Provides Derivatives Data for EMIR Refit Regulation
LONDON–(BUSINESS WIRE)–SmartStream Reference Data Services (RDS), a leading provider of financial reference data, has announced the launch of an enhanced... Read more.
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
Clareon PCIOLs deliver excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free§ IOL material12-14 Clareon IOLs offer long-lasting... Read more.
Gartner Announces Inaugural Gartner Marketing Symposium/Xpo in London
STAMFORD, Conn.–(BUSINESS WIRE)–Gartner, Inc. (NYSE: IT): What: Gartner Marketing Symposium/Xpo When: May 13-14, 2024 Where: London, U.K. Members of... Read more.
Beeworks Games: Mobile Game “Idle Mushroom Garden Deluxe” Released in English for iOS/Android
The Popular Mushroom Farming Simulation App Expands Reach Globally TOKYO–(BUSINESS WIRE)–#AppStore–Japanese mobile-game developer Beeworks Games... Read more.
Capcom’s Monster Hunter: World Tops 25 Million Units Sold Globally!
Sets new Capcom record-high for single-title sales in the series’ 20th anniversary year OSAKA, Japan–(BUSINESS WIRE)–#Capcom–Capcom Co., Ltd.... Read more.
Celebrated Southern California Restaurateur Brings New Italian Culinary Experience to Irvine
EMMES and Oaktree Redefine Irvine’s Office Landscape, Sign 8th Restaurant at Centerview IRVINE, Calif.–(BUSINESS WIRE)–In just four years, in the midst... Read more.
Tide Set to Launch in Germany
Tide is UK’s leading business financial platform with Germany becoming Tide’s second market outside the UK following its 2022 launch in India LONDON–(BUSINESS... Read more.
MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference
Oral presentation will highlight new data in Early Access Program (EAP) for patients with acute Graft-vs-Host Disease (aGvHD) treated with MaaT013. This is the seventh... Read more.
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024
Rate of visual improvement (Clinically Relevant Recovery, or CRR) among patients treated with LUMEVOQ® gene therapy is greater than that of idebenone-treated patients... Read more.